For adults with moderately to severely active ulcerative colitis (UC) who are corticosteroid dependent or have failed or were intolerant to conventional therapy
SIMPONI® (golimumab) Dosing and Administration
SIMPONI® injection schedule for UC1
Week 0: 2 (100-mg) injections
Week 2: 1 (100-mg) injection
Week 6 and every 4 weeks thereafter:
1 (100-mg) injection
Each 100-mg single-dose SmartJect® autoinjector contains a prefilled glass syringe providing 100 mg of SIMPONI® per 1 mL of solution. Also available in a 100-mg prefilled syringe.
SIMPONI® is intended for use under the guidance and supervision of a physician. Patients may self-inject SIMPONI® after physician approval and proper training.
Prior to initiating SIMPONI® and periodically during therapy, patients should be evaluated for active tuberculosis and tested for latent infection. Prior to initiating SIMPONI®, patients should be tested for hepatitis B viral infection.
• SIMPONI® uses an L-histidine-based injection buffer1
SmartJect® autoinjector training video
This video demonstrates the necessary steps you can take to help properly teach your patients to inject their SIMPONI® using the SmartJect® autoinjector.